Carnegie Mellon University is a private research university based in Pittsburgh, Pennsylvania. It is the result of a merger of the Carnegie Institute of Technology and the Mellon Institute of Industrial Research.

During the past decade, Carnegie Mellon University conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 1 clinical trials were completed, i.e. on average, 4.3% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 1 clinical trials were completed. i.e. 14.3% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Carnegie Mellon University" #1 collaborator was "University of Pittsburgh" with 6 trials as a collaborator, "Carnegie Mellon University" with 3 trials as a collaborator, "Penn State University" with 3 trials as a collaborator, "National Institute on Aging (NIA)" with 2 trials as a collaborator and "National Institutes of Health (NIH)" with 2 trials as a collaborator. Other collaborators include 14 different institutions and companies that were collaborators in the rest 23 trials.

According to Clinical.Site data, the most researched conditions in "Carnegie Mellon University" are "Obesity" (5 trials), "Cardiac Transplant Disorder" (4 trials), "Psychological Stress" (4 trials), "Depression" (2 trials) and "Healthy" (2 trials). Many other conditions were trialed in "Carnegie Mellon University" in a lesser frequency.

Most popular intervention types in "Carnegie Mellon University" are "Behavioral" (19 trials), "Other" (11 trials), "Device" (1 trials), "Drug" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Mindfulness Training" (3 trials), "Stratified Transplant Survival" (3 trials), "150 Minutes Week" (1 trials), "225 Minutes Week" (1 trials) and "Alcohol" (1 trials). Other intervention names were less common.

The vast majority of trials in "Carnegie Mellon University" are 30 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Carnegie Mellon University". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 25 completed trials in Carnegie Mellon University, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Carnegie Mellon University, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 26 trials that are defined as “Not Applicable".